These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8677031)

  • 1. Treatment with antiepileptic drugs: possible neuroprotective effects.
    Pitkänen A
    Neurology; 1996 Jul; 47(1 Suppl 1):S12-6. PubMed ID: 8677031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy.
    Bethmann K; Fritschy JM; Brandt C; Löscher W
    Neurobiol Dis; 2008 Aug; 31(2):169-87. PubMed ID: 18562204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles.
    Agosti R; Yasargil G; Egli M; Wieser HG; Wiestler OD
    Epilepsy Res; 1990 Jul; 6(2):166-70. PubMed ID: 2387287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of neuronal cell death by anticonvulsants in experimental epilepsy (extended abstract).
    Pitkänen A; Halonen T
    Acta Neurol Scand Suppl; 1995; 162():22-3. PubMed ID: 7495184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic and severe behavioural reactions with vigabatrin: a review.
    Ferrie CD; Robinson RO; Panayiotopoulos CP
    Acta Neurol Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8825264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, gamma-aminobutyric acid and dopamine levels, a microdialysis-electrocorticography study in freely moving rats.
    Smolders I; Khan GM; Lindekens H; Prikken S; Marvin CA; Manil J; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1239-48. PubMed ID: 9399999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin.
    Calli J; Farrington E
    Pediatr Nurs; 1998; 24(4):357-61. PubMed ID: 9849270
    [No Abstract]   [Full Text] [Related]  

  • 9. Vigabatrin.
    Shields WD; Sankar R
    Semin Pediatr Neurol; 1997 Mar; 4(1):43-50. PubMed ID: 9097366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
    Androsova G; Krause R; Borghei M; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Koeleman BPC; Kunz WS; Lerche H; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Sisodiya SM; Depondt C;
    Epilepsia; 2017 Oct; 58(10):1734-1741. PubMed ID: 28857179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin.
    Guberman A
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of vigabatrin: a review.
    Monaco F
    Neurology; 1996 Jul; 47(1 Suppl 1):S6-11. PubMed ID: 8677033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
    Halonen T; Kotti T; Tuunanen J; Toppinen A; Miettinen R; Riekkinen PJ
    Brain Res; 1995 Sep; 693(1-2):217-24. PubMed ID: 8653412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.
    Halonen T; Miettinen R; Toppinen A; Tuunanen J; Kotti T; Riekkinen PJ
    Neurosci Lett; 1995 Jul; 195(1):13-6. PubMed ID: 7478243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala.
    Pitkänen A; Tuunanen J; Halonen T
    Epilepsy Res; 1996 May; 24(1):29-45. PubMed ID: 8800633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lamotrigine and topiramate on hippocampal neurogenesis in experimental temporal-lobe epilepsy.
    Chen J; Quan QY; Yang F; Wang Y; Wang JC; Zhao G; Jiang W
    Brain Res; 2010 Feb; 1313():270-82. PubMed ID: 20025852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages and disadvantages of new antiepileptic drugs].
    Herranz JL
    Rev Neurol; 1996 Nov; 24(135):1426-34. PubMed ID: 8974750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.